Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KYNB

KYNTRA BIO, INC.

CIK 0000921299 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$7.52
↑ 0.20 (2.73%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$30.45M
P/E Ratio
0.17
EPS
45.37
Dividend Yield
Not covered
52W Position
19%
Beta
1.09

Valuation multiples

Fwd P/E
61.35
PEG
Not covered
P/B
-1.03
P/S
6.60
EV/Revenue
-4.37
ROE
-618.4%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 19%
$6.32$12.60

Latest Financials

2025-12-31 FY
Revenue
$6.44M
Net Income
$183.45M
Total Assets
$119.59M
Free Cash Flow
-$4.81M

Recent news